Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysine-specific cysteine proteinase (gingipain K) is a major proteolytic virulence factor produced by *Porphyromonas gingivalis*. It cleaves peptide bonds at the carboxyl side of lysine residues, facilitating bacterial survival, tissue invasion, and immune evasion. As it is essential for bacterial pathogenicity and absent from humans, it represents an attractive target for selective inhibitor development aimed at treating periodontitis.
Inhibition of proteolytic activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysine-specific cysteine proteinase (Kgp).